During the past decade, Massachusetts Institute of Technology conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Massachusetts Institute of Technology" #1 sponsor was "Massachusetts Institute of Technology" with 11 trials, followed by "Beth Israel Deaconess Medical Center" with 3 trials sponsored, "Massachusetts General Hospital" with 2 trials sponsored, "Amy Finkelstein" with 1 trials sponsored and "Boston Children's Hospital" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts Institute of Technology" #1 collaborator was "Massachusetts General Hospital" with 5 trials as a collaborator, "Massachusetts Institute of Technology" with 5 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Boston Children's Hospital" with 1 trials as a collaborator and "Code3" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Massachusetts Institute of Technology" are "Alzheimer Disease" (2 trials), "Amputation" (2 trials), "Melanoma (Skin)" (2 trials), "Alcohol Abuse" (1 trials) and "Alzheimer Dementia" (1 trials). Many other conditions were trialed in "Massachusetts Institute of Technology" in a lesser frequency.

Most popular intervention types in "Massachusetts Institute of Technology" are "Behavioral" (5 trials), "Device" (5 trials), "Drug" (4 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "GENUS device (Active Settings)" (4 trials), "GENUS device (Sham Settings)" (3 trials), ""CRT device" hydration status measurement" (1 trials), ""RF wristband" hydration status measurement" (1 trials) and "AMI transtibial amputation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts Institute of Technology" are 18 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Massachusetts Institute of Technology". 2 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Massachusetts Institute of Technology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts Institute of Technology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 15 trials that are defined as “Not Applicable".